glp-1 agonists and inflammation Anti-inflammatory role of glucagon-like peptide 1 receptor its clinical implications Central glucagon-like peptide 1 receptor

Among patients with PCOS who had a semaglutide or tirzepatide prescription, the percentage of patients prescribed tirzepatide increased, while semaglutide use declined over time

Adverse events linked to GLP-1 medicines The most common side effects of GLP-1RAs are gastrointestinal, including nausea, diarrhea, constipation, and vomiting

Experiencing mild side effects during the first few weeks of GLP-1 therapy is common

All Other Customers, 2021 to 2025 Exhibit 184: McKesson, Revenues from Rite Aid, 2016 to 2025 Exhibit 185: Cardinal Health, Revenues from Optum Rx, 2016 to 2024 Exhibit 186: McKesson, U.S

[DOI] [PubMed] [Google Scholar] 62.Krajewski P.K., Zotowska A., Szepietowski J.C